← Leaderboards
Xiaoyang Wu
University Of Chicago
$5,862,035
Attributed
$7,370,660
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,370,660 · 6
By mechanism
R01$6,288,530 · 3
R21$822,130 · 2
R34$260,000 · 1
Top collaborators
- Ming Xu7 shared
- Sangram S Sisodia1 shared
Most similar at University Of Chicago
Same institution · by research overlap
- Michael I Nishimura$19,220,002
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsIn VivoSkinStem CellsGene TherapyEngineeringTissuesResponseOrganIn VitroCutaneousTransplantationSkin TransplantationMouse ModelPreventAutologous TransplantationImmunocompetentProteinsPlasmaCrispr/Cas TechnologyPlayRelapseAttenuatedAnimals
Grant awards (21)
Coordinated cytoskeletal and cell adhesion dynamics in vesicant induced skin injury$260,000
R34 · FY2025 · AR · contact PI
A cutaneous gene therapy for cocaine abuse and alcohol co-abuse$437,400
R01 · FY2023 · DA
Development of a novel lymphocyte engineering approach for treatment of vitiligo$180,400
R21 · FY2023 · AR · contact PI
A cutaneous gene therapy for cocaine abuse and alcohol co-abuse$437,400
R01 · FY2022 · DA
Development of a novel lymphocyte engineering approach for treatment of vitiligo$216,480
R21 · FY2022 · AR · contact PI
A cutaneous gene therapy for cocaine abuse and alcohol co-abuse$437,400
R01 · FY2021 · DA
Development of epidermal progenitor cell-based therapy for regenerative medicine$405,000
R01 · FY2021 · OD · contact PI
A cutaneous gene therapy for cocaine abuse and alcohol co-abuse$437,400
R01 · FY2020 · DA
Development of epidermal progenitor cell-based therapy for regenerative medicine$405,000
R01 · FY2020 · OD · contact PI
A cutaneous gene therapy for cocaine abuse and alcohol co-abuse$437,400
R01 · FY2019 · DA
Development of epidermal progenitor cell-based therapy for regenerative medicine$405,000
R01 · FY2019 · OD · contact PI
Development of epidermal progenitor cell-based therapy for regenerative medicine$405,000
R01 · FY2019 · OD · contact PI
A Novel cutaneous gene therapy for combating alcohol use disorder$192,375
R21 · FY2019 · AA
Development of epidermal progenitor cell-based therapy for regenerative medicine$405,000
R01 · FY2018 · OD · contact PI
A Novel cutaneous gene therapy for combating alcohol use disorder$232,875
R21 · FY2018 · AA
Development of epidermal progenitor cell-based therapy for regenerative medicine$383,860
R01 · FY2017 · OD · contact PI
Coordinated cytoskeletal dynamics in skin somatic stem cells - Resubmission 01$336,069
R01 · FY2017 · AR · contact PI
Coordinated cytoskeletal dynamics in skin somatic stem cells - Resubmission 01$336,069
R01 · FY2016 · AR · contact PI
Coordinated cytoskeletal dynamics in skin somatic stem cells - Resubmission 01$336,069
R01 · FY2015 · AR · contact PI
Coordinated cytoskeletal dynamics in skin somatic stem cells - Resubmission 01$336,069
R01 · FY2014 · AR · contact PI
Coordinated cytoskeletal dynamics in skin somatic stem cells - Resubmission 01$348,394
R01 · FY2013 · AR · contact PI